Kate Shemirani's sons told the BBC news program 'Panorama' that they believe she discouraged their sister from seeking ...

In a cohort of TRANSCEND FL, the chimeric antigen receptor T-cell therapy liso-cel showed a 95% overall response rate in relapsed marginal zone lymphoma, offering hope for improved patient outcomes in ...

Dave Coulier recalled the moment he got diagnosed with cancer, his immunity problems after chemotherapy, and the beacons of ...

Dylan Williams (14) is currently in his third week of chemotherapy and lumbar punctures after being diagnosed with ...

(12/20) complete response rate after treatment with EO2463 in combination with lenalidomide and rituximab (R2) <li /> EO ...

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

The FDA has approved Monjuvi (tafasitamab) for relapsed follicular lymphoma, offering hope with improved progression-free ...

The American Society for Transplantation and Cellular Therapy is proud to announce the release of a refreshed Practice ...

Approval was based on results from the Phase III inMIND trial, which demonstrated a statistically significant and clinically ...

A 12-year old cancer survivor from the Chicago area got the wish of a lifetime on Friday. Valentina Robles was able to pet ...

Tafasitamab-cxix gains FDA approval for relapsed follicular lymphoma, showcasing significant progression-free survival ...